Patrick J. Gannon, Ph.D.
Affiliations: | Pharmacology | University of Pennsylvania, Philadelphia, PA, United States |
Area:
Molecular mechanisms underlying neuronal loss in neurodegenerative disordersGoogle:
"Patrick Gannon"Mean distance: 19.15 (cluster 32)
Parents
Sign in to add mentor| Kelly L. Jordan-Sciutto | grad student | 2014 | Penn | |
| (Assessing the contribution of antiretroviral therapy to neuronal damage and death as a mediator of cognitive decline in HIV-associated neurocognitive disorders.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Bond S, Lopez-Lloreda C, Gannon PJ, et al. (2020) The Integrated Stress Response and Phosphorylated Eukaryotic Initiation Factor 2α in Neurodegeneration. Journal of Neuropathology and Experimental Neurology |
| Stern AL, Ghura S, Gannon PJ, et al. (2018) BACE1 mediates HIV-associated and excitotoxic neuronal damage through an APP-dependent mechanism. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience |
| Gannon PJ, Akay-Espinoza C, Yee AC, et al. (2017) HIV Protease Inhibitors Alter Amyloid Precursor Protein Processing via β-Site Amyloid Precursor Protein Cleaving Enzyme-1 Translational Up-Regulation. The American Journal of Pathology. 187: 91-109 |
| Jensen BK, Monnerie H, Mannell MV, et al. (2015) Altered Oligodendrocyte Maturation and Myelin Maintenance: The Role of Antiretrovirals in HIV-Associated Neurocognitive Disorders. Journal of Neuropathology and Experimental Neurology. 74: 1093-118 |
| Akay C, Cooper M, Odeleye A, et al. (2014) Antiretroviral drugs induce oxidative stress and neuronal damage in the central nervous system. Journal of Neurovirology. 20: 39-53 |
| Gannon P, Khan MZ, Kolson DL. (2011) Current understanding of HIV-associated neurocognitive disorders pathogenesis. Current Opinion in Neurology. 24: 275-83 |